Product Information

CIMETIDINE 400 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3068 per EA under NDC 00093820401. Its NADAC has been published 573 times since Nov 28, 2013.

FDA first approved this application on May 17, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Cimetidine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CIMETIDINE 400 MG TABLET has been published 573 times since Nov 28, 2013, and over the history we have for it it has risen 13.2%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.